Current anti-obesity pharmacotherapy includes 5 FDA-approved medications: orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, and semaglutide (Table 2), as well as phentermine, which is approved only for short term use
Targets specific areas with a high concentration of fat
Free dosage tool
Acknowledgements This study was financially supported by grants from the Academy of Finland (AK297267, AK328443, and KK296840, KK333302), the Kuopio University Hospital VTR grant (KK5503743), the Emil Aaltonen Foundation, the Sigrid Juselius Foundation, the Pivikki and Sakari Sohlberg Foundation, the Finnish Cultural Foundation, and the Finnish Eye Foundation
It is not intended for human consumption, therapeutic use, medical use or diagnostic application
Bliddal et al